top of page

CONDITIONS · NEUROENDOCRINE HEALTH

Neuroendocrine
Tumours 
(NETs)

A diverse group of rare tumours that arise from the body's hormone-producing cells. They often grow slowly and can be very treatable — but because their symptoms are subtle and varied, expert assessment and coordinated care are essential. Specialist endocrine input from consultant Dr Sheharyar Qureshi.

ChatGPT Image Aug 16, 2026, 09_15_05 PM.png

At a glance

  • Arise from neuroendocrine cells found throughout the body

  • Most commonly occur in the digestive system and lungs

  • Often slow-growing, and frequently very treatable

  • Best managed through specialist, multidisciplinary care

01 — UNDERSTANDING THE CONDITION

What are neuroendocrine tumours?

Neuroendocrine tumours are a varied group of tumours that develop from neuroendocrine cells — specialised cells that are found throughout the body and share features of both nerve and hormone-producing cells. These cells help regulate many bodily processes by releasing hormones into the bloodstream. Because they are so widely distributed, NETs can arise in many different organs, most commonly in the digestive system (the stomach, bowel and pancreas) and the lungs.

NETs vary enormously. Some are "functioning" — meaning they release excess hormones that cause distinctive symptoms — while others are "non-functioning" and may cause no hormonal symptoms at all, coming to light only when they grow large enough to be noticed or are found incidentally on a scan. Many NETs grow slowly over long periods, though a minority behave more actively.

This diversity is why NETs are best assessed by specialists. An endocrinologist plays an important role in the team — particularly in identifying and managing the hormonal effects of functioning tumours, and in coordinating the wider assessment needed to understand each individual tumour.

02 — SIGNS & SYMPTOMS

How NETs can present

Symptoms depend heavily on whether a tumour produces excess hormones, and on where it is located. Many symptoms are non-specific and can mimic far more common conditions — one reason NETs can take time to diagnose.

Hormone-related

The pattern of symptoms depends on which hormone is being overproduced.

Functioning tumours

When a tumour releases excess hormones

  • Flushing of the skin and diarrhoea (carcinoid syndrome)

  • Episodes of low blood sugar, sweating and confusion

  • Recurrent stomach ulcers and reflux

  • Wheezing or a rapid heartbeat during episodes

Local or non-specific

These are often found incidentally, or cause symptoms only as they grow.

Non-functioning tumours

When a tumour produces no excess hormone

  • Vague abdominal discomfort or bloating

  • A change in bowel habit

  • Unexplained tiredness or weight change

  • Often discovered on a scan done for another reason

03 — THE TYPES WE HELP ASSESS

Types of neuroendocrine tumour

NETs are grouped by where they arise and whether they produce excess hormones. These are some of the more commonly encountered types.

Gastrointestinal NETs

Stomach, bowel & more

The most common site for NETs. Often slow-growing, historically referred to in some cases as "carcinoid" tumours.

Pancreatic NETs

Arising in the pancreas

NETs of the pancreas, which may be functioning or non-functioning. This group includes insulinoma and gastrinoma.

Lung NETs

Bronchial tumours

NETs arising in the lungs, spanning a range from slow-growing to more active forms, assessed alongside respiratory specialists.

Insulinoma

Excess insulin

A usually benign pancreatic NET producing excess insulin, causing episodes of low blood sugar (hypoglycaemia).

Gastrinoma

Excess gastrin

A NET producing excess gastrin, leading to high stomach acid and recurrent ulcers (Zollinger–Ellison syndrome).

Functioning & non-functioning

A key distinction

Whether a tumour releases excess hormones shapes its symptoms and its management — a central question in every assessment.

04 — DIAGNOSIS

How NETs are diagnosed

Diagnosing a NET usually involves several complementary tests — measuring hormones and markers in the blood or urine, specialised imaging, and confirming the diagnosis with a tissue sample. The endocrine element focuses on the hormonal picture.

Detailed consultation

A careful review of your symptoms and their pattern over time, your medical and family history, and a clinical examination.

01

Blood & urine tests

Measuring specific hormones and markers associated with NETs to assess whether a tumour is producing excess hormone, and to help monitor over time.

02

Specialised imaging

Cross-sectional scans (CT or MRI) alongside dedicated NET imaging techniques that can locate tumours and show their extent with precision.

03

Biopsy & specialist review

Where appropriate, a tissue sample confirms the diagnosis and its characteristics, with findings reviewed by a specialist multidisciplinary team.

04

05 — TREATMENT & MANAGEMENT

A plan shaped around the individual tumour

There is no single treatment for NETs — the right approach depends on the tumour's type, location, behaviour and whether it produces excess hormones. Many NETs are managed successfully over the long term. Treatment is always planned by a specialist multidisciplinary team.

01

Active monitoring

For some slow-growing tumours, careful surveillance over time is an appropriate and evidence-based approach, with treatment introduced only if needed.

03

Controlling hormone effects

For functioning tumours, specific medical treatments can control the excess-hormone symptoms very effectively, greatly improving day-to-day quality of life.

02

Surgery

Where a tumour can be removed, surgery may offer the best outcome — sometimes resolving the condition entirely. Suitability is assessed case by case.

03

Specialist therapies

A range of further options exists for more advanced tumours, delivered through specialist NET centres. Your team will explain which are relevant to you.

06 — COORDINATED, SPECIALIST CARE

The value of a joined-up team

NETs are best managed by a specialist multidisciplinary team, where experts from different fields plan care together. As an endocrinologist, Dr Qureshi contributes particular expertise in the hormonal aspects of NETs — and in ensuring your care is coordinated and clearly explained.

  • Expert assessment and control of hormone-related symptoms

  • Coordination with oncology, surgery, radiology and specialist NET centres

  • Clear guidance through each stage of assessment and treatment

  • A consistent point of contact who knows your history

7xm.xyz412640.jpg

07 — COMMON QUESTIONS

Neuroendocrine tumours, answered

SPEAK TO A SPECIALIST

Expert, coordinated NET care

If you have symptoms that may relate to a neuroendocrine tumour, or have had results or a scan that need specialist interpretation, Dr Qureshi offers thorough endocrine assessment and coordinated, personalised care — discreetly and without delay.

This page is for general information only and does not constitute medical advice. It is not a substitute for a consultation with a qualified clinician. Neuroendocrine tumours are complex and best managed by a specialist multidisciplinary team. If you have concerns about your health, please seek personalised advice from your doctor or arrange an appointment with our clinic.

bottom of page